Log In
BCIQ
Print this Print this
 

PRX004

  Manage Alerts
Collapse Summary General Information
Company Prothena Corp. plc
Description 
Molecular Target Transthyretin (TTR)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyloidosis
Indication DetailsTreat TTR amyloidosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today